Mid-term evaluation of the Estonian national HIV/AIDS strategy 2006–2015 and national drug prevention strategy 2012: report
Copenhagen; World Health Organization. Regional Office for Europe; 2011. (WHO/EURO:2011-4425-44188-62393).
in English
| WHO IRIS
| ID: who-350267
Responsible library:
CH1.1
ABSTRACT
This is the latest in a series of evaluations of Estonia’s response to HIV conducted jointly by WHO and UNODC. The most recent one was conducted in 2008. Since then, there have been remarkable achievements. Most of the suggested recommendations have been accepted and acted on. The national programme has become much more focused, better prioritized and better managed. Valuable lessons have been learned, that are useful beyond the HIV programme. Overall, the HIV programme in Estonia can be considered a very successful modern public health programme in Europe.
Full text:
Available
Collection:
Databases of international organizations
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
/
Neglected Diseases
Health problem:
Goal 9: Noncommunicable diseases and mental health
/
Target 3.3: End transmission of communicable diseases
/
Target 3.9: Reduce the amount of deaths produced by dangerous chemicals and the pollution of the air, water and soil
/
Target 3.5: Prevention and treatment of consumption of psychoactive substances
/
Neglected Diseases
/
Tuberculosis
Database:
WHO IRIS
Main subject:
Quality of Health Care
/
Tuberculosis
/
Strategic Planning
/
Illicit Drugs
/
HIV Infections
/
Acquired Immunodeficiency Syndrome
/
Estonia
/
Health Planning
/
Health Services
Country/Region as subject:
Europa
Language:
English
Year:
2011
